drugset / Trial / NCT01497574
Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of the pharmacokinetic profiles of insulin detemir and insulin glargine in children and adolescents with type 1 diabetes.
Timeline
- Start
- 2005-05
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin detemir | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |
| Subject | insulin glargine | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |